Tag: Prescription Drugs

Displaying 1 - 20 of 264 results.

Pages

 Today, U.S. District Court Judge Denise Cote held “Pharma Bro” Martin Shkreli liable for antitrust claims brought by the Federal Trade Commission and a group of seven state enforcers.  Finding that Shkreli’s conduct was “egregious, deliberate, repetitive, long-running, and ultimately dangerous,”...
The Federal Trade Commission and its state co-plaintiffs, New York, California, Illinois, North Carolina, Ohio, Pennsylvania, and Virginia, filed an order in court today that shuts down an illegal scheme masterminded by ‘Pharma Bro’ Martin Shkreli that fleeced patients dependent on the life-saving...
The Federal Trade Commission required generic drug marketers ANI Pharmaceuticals, Inc. and Novitium Pharma LLC to divest, to Prasco LLC, ANI’s development rights to one generic drug and assets with respect to another generic drug as part of a settlement resolving charges that ANI’s $...
The staff of the Federal Trade Commission has issued an opinion advising Doylestown Health Physicians that an exemption under the Non-Profit Institutions Act applies to its proposal to sell discounted pharmaceuticals and medical devices to its affiliated hospital, Doylestown Hospital.
After the Supreme Court declined to review a ruling from the Third Circuit that AbbVie used sham litigation to illegally maintain a monopoly, the Federal Trade Commission has withdrawn the remaining count in its complaint.
Staff from the Federal Trade Commission, Canada’s Competition Bureau, the European Commission Directorate General for Competition, the U.K.’s Competition and Markets Authority, the U.S.
The Federal Trade Commission is sending 51,875 payments totaling more than $59 million to consumers who were victims of an allegedly deceptive scheme by Reckitt Benckiser Group and
Note: The FTC will host a conference call TODAY for media at 11:30 ET with Acting Chairwoman Rebecca Kelly Slaughter. The call-in number is 844-291-6360 and the access code is 4928954. Call-in lines, which are for media only, will open 15 minutes prior to the start of the call.
The FTC is suing Endo Pharmaceuticals, Inc., Endo International plc, Impax Laboratories, LLC, and Impax’s owner, Amneal Pharmaceuticals, Inc., alleging that a 2017 agreement between Endo and Impax violated the antitrust laws by eliminating competition in the market for oxymorphone ER...
The FTC is suing Endo Pharmaceuticals Inc., Endo International plc, Impax Laboratories, LLC, and Impax’s owner, Amneal Pharmaceuticals, Inc., alleging that a 2017 agreement between Endo and Impax violated the antitrust laws by eliminating competition in the market for oxymorphone ER. The FTC sued...

Pages